NCT04252560Completed
The Impact of Gut Microbiota in Anastomoses Insufficiency After Resection and Direct Anastomosis for Colorectal Cancer.
Source: ClinicalTrials.gov · Last updated 9 May 2024
Brief summary (registry, in English)
The role of gut microbiota in anastomosis insufficiency in patients operated for colorectal cancer and for peritoneal carcinomatosis is going to be investigated. This is a pilot study.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 45 (actual)
- First submitted
- 31 Jan 2020
- Start date
- Jan 2020
- Primary completion date
- Jan 2024
- Lead sponsor
- Uppsala University Hospital
- Diseases
- Colorectal cancer
- NCT number
- NCT04252560
What you commit to
- Study type: Observational
- Participants enrolled: 45
- From Jan 2020 to the primary completion date, Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- acute surgery
- palliative surgery
- Prior colectomy
Other illness
- Ulcerös colitis or Crohns disease
Other
- Ongoing antibiotics treatment
- antibiotics treatment in the last 6 months
- Small intestine stoma before the operation
- neoadjuvant treatment
- Colon preparation
Who the study is looking for
- adenocarcinom in colon or rektum
- curative operation planed
- direct anastomose plan
- elective surgery
- All patients with appendix, colon or rectal cancer accepted for CRS+HIPEC
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Uppsala University Hospital Coordinator of this site? Confirm its status | Uppsala | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.